Bart A. van den Berg
Fondatore presso VenGen BV
Profilo
Bart van den Berg holds an MSc in Business Economics from Tilburg University.
He worked as a consultant before he founded two pharmaceutical contract-manufacturing companies.
Together with Alfred Nijkerk he founded VenGen in 2001.
Since then, he has co-founded several life science start ups including FlexGen.
In 2004 Bart joined the VenGen venture DiagnOptics as Managing Director.
Posizioni attive di Bart A. van den Berg
| Società | Posizione | Inizio |
|---|---|---|
VenGen BV
 VenGen BV Investment ManagersFinance VenGen BV is an independent venture capital investment firm based in Amsterdam. VenGen was founded in 2001 by Alfred Nijkerk, Bart van den Berg and Jaap Blaak. The firm's name is short for 'venture genesis' or rather the origin of venture. The firm provides venture capital to scientists and entrepreneurs operating in the field of life sciences. | Fondatore | 01/07/2001 |
Diagnoptics Technologies BV
 Diagnoptics Technologies BV Medical SpecialtiesHealth Technology DiagnOptics Technologies BV develops and manufactures diagnostic devices that can non-invasively diagnose and assess the risk of diabetes and its complications. The firm’s AGE reader diagnoses and assesses the risk of cardiovascular, diseases through measuring tissue accumulation of AGEs. The company was founded by Reindert Graaff and Andries J. Smit in 2003 and is headquartered in Groningen, the Netherlands. | Amministratore Delegato | 01/06/2004 |
Formazione di Bart A. van den Berg
| University of Tilburg | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
VenGen BV
VenGen BV Investment ManagersFinance VenGen BV is an independent venture capital investment firm based in Amsterdam. VenGen was founded in 2001 by Alfred Nijkerk, Bart van den Berg and Jaap Blaak. The firm's name is short for 'venture genesis' or rather the origin of venture. The firm provides venture capital to scientists and entrepreneurs operating in the field of life sciences. | Finance |
Diagnoptics Technologies BV
Diagnoptics Technologies BV Medical SpecialtiesHealth Technology DiagnOptics Technologies BV develops and manufactures diagnostic devices that can non-invasively diagnose and assess the risk of diabetes and its complications. The firm’s AGE reader diagnoses and assesses the risk of cardiovascular, diseases through measuring tissue accumulation of AGEs. The company was founded by Reindert Graaff and Andries J. Smit in 2003 and is headquartered in Groningen, the Netherlands. | Health Technology |
- Borsa valori
- Insiders
- Bart A. van den Berg
